Grant Thornton acted as the buy-side transaction advisor, supporting Fagron in acquisition of assets related to the pharmaceutical raw materials segment.
The acquisition of selected assets of Amara will broaden Fagron’s offering in Poland and unlock significant synergy potential through scale effects and operational optimisation.
Fagron is the leading global company active in pharmaceutical compounding, focusing on delivering personalised therapies to hospitals, pharmacies, clinics, and patients in more than 35 countries around the world.
Amara is a relevant player in the compounding sector, operating in the area of pharmaceutical raw materials in Poland. The company has over 30 years of experience and numerous active registrations, which are essential for operating on the Polish market.
Our transactions
